Cardiometabolic Benefits of Intermittent Fasting
This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed here-alternate-day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE)-produced mild to moderate weight loss (1-8% from baseline) and consistent r...
Uložené v:
| Vydané v: | Annual review of nutrition Ročník 41; s. 333 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
11.10.2021
|
| Predmet: | |
| ISSN: | 1545-4312, 1545-4312 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed here-alternate-day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE)-produced mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline). These regimens may benefit cardiometabolic health by decreasing blood pressure, insulin resistance, and oxidative stress. Low-density lipoprotein cholesterol and triglyceride levels are also lowered, but findings are variable. Other health benefits, such as improved appetite regulation and favorable changes in the diversity of the gut microbiome, have also been demonstrated, but evidence for these effects is limited. Intermittent fasting is generally safe and does not result in energy level disturbances or increased disordered eating behaviors. In summary, intermittent fasting is a safe diet therapy that can produce clinically significant weight loss (>5%) and improve several markers of metabolic health in individuals with obesity. |
|---|---|
| AbstractList | This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed here-alternate-day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE)-produced mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline). These regimens may benefit cardiometabolic health by decreasing blood pressure, insulin resistance, and oxidative stress. Low-density lipoprotein cholesterol and triglyceride levels are also lowered, but findings are variable. Other health benefits, such as improved appetite regulation and favorable changes in the diversity of the gut microbiome, have also been demonstrated, but evidence for these effects is limited. Intermittent fasting is generally safe and does not result in energy level disturbances or increased disordered eating behaviors. In summary, intermittent fasting is a safe diet therapy that can produce clinically significant weight loss (>5%) and improve several markers of metabolic health in individuals with obesity.This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed here-alternate-day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE)-produced mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline). These regimens may benefit cardiometabolic health by decreasing blood pressure, insulin resistance, and oxidative stress. Low-density lipoprotein cholesterol and triglyceride levels are also lowered, but findings are variable. Other health benefits, such as improved appetite regulation and favorable changes in the diversity of the gut microbiome, have also been demonstrated, but evidence for these effects is limited. Intermittent fasting is generally safe and does not result in energy level disturbances or increased disordered eating behaviors. In summary, intermittent fasting is a safe diet therapy that can produce clinically significant weight loss (>5%) and improve several markers of metabolic health in individuals with obesity. This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed here-alternate-day fasting (ADF), the 5:2 diet, and time-restricted eating (TRE)-produced mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline). These regimens may benefit cardiometabolic health by decreasing blood pressure, insulin resistance, and oxidative stress. Low-density lipoprotein cholesterol and triglyceride levels are also lowered, but findings are variable. Other health benefits, such as improved appetite regulation and favorable changes in the diversity of the gut microbiome, have also been demonstrated, but evidence for these effects is limited. Intermittent fasting is generally safe and does not result in energy level disturbances or increased disordered eating behaviors. In summary, intermittent fasting is a safe diet therapy that can produce clinically significant weight loss (>5%) and improve several markers of metabolic health in individuals with obesity. |
| Author | Ezpeleta, Mark Cienfuegos, Sofia Gabel, Kelsey Varady, Krista A |
| Author_xml | – sequence: 1 givenname: Krista A surname: Varady fullname: Varady, Krista A email: varady@uic.edu organization: Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612, USA; email: varady@uic.edu – sequence: 2 givenname: Sofia surname: Cienfuegos fullname: Cienfuegos, Sofia email: varady@uic.edu organization: Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612, USA; email: varady@uic.edu – sequence: 3 givenname: Mark surname: Ezpeleta fullname: Ezpeleta, Mark email: varady@uic.edu organization: Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612, USA; email: varady@uic.edu – sequence: 4 givenname: Kelsey surname: Gabel fullname: Gabel, Kelsey email: varady@uic.edu organization: Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612, USA; email: varady@uic.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34633860$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj09LxDAUxIOsuH_0K0jx5CX6kjRpe9RlVxcWvOi5JO17UmnTNUkFv70LriAMzBx-DDNLNvOjR8ZuBNwJkZt76_0U8Iv7KQUOWoIEDrlQsjhjC6FzzXMl5OxfnrNljB8AUCmlLthc5Uap0sCCwdqGthsHTNaNfddkj-iRuhSzkbKdTxiGLiX0KdvamDr_fsnOyfYRr06-Ym_bzev6me9fnnbrhz23qtCJl1CaqrHWWcgNtWTJCSLjjhPQaCIAraSrTKssCYFAhFhoaLEk1xSVkSt2-9t7COPnhDHVQxcb7HvrcZxiLXUp5FGiOKLXJ3RyA7b1IXSDDd_130v5A97bWko |
| CitedBy_id | crossref_primary_10_1159_000530269 crossref_primary_10_1177_11795468231170779 crossref_primary_10_3389_fcvm_2023_1251122 crossref_primary_10_1093_jncimonographs_lgad008 crossref_primary_10_3390_nu16203528 crossref_primary_10_1051_e3sconf_202455305016 crossref_primary_10_3390_nu17071130 crossref_primary_10_3389_fpubh_2025_1640512 crossref_primary_10_3390_nu14112343 crossref_primary_10_1186_s12937_022_00790_0 crossref_primary_10_1007_s13668_024_00569_1 crossref_primary_10_1007_s13679_022_00491_z crossref_primary_10_1159_000540068 crossref_primary_10_3390_nu16010168 crossref_primary_10_1111_dom_70142 crossref_primary_10_1017_S0967199424000108 crossref_primary_10_1007_s13679_025_00645_9 crossref_primary_10_1155_ije_6658512 crossref_primary_10_3389_fendo_2025_1576599 crossref_primary_10_1016_j_cmet_2024_06_013 crossref_primary_10_47286_01211463_623 crossref_primary_10_1002_oby_23579 crossref_primary_10_1007_s12265_023_10443_0 crossref_primary_10_1186_s13063_023_07843_7 crossref_primary_10_1016_j_cct_2025_108049 crossref_primary_10_1016_j_clnu_2025_08_004 crossref_primary_10_1038_s41366_024_01641_0 crossref_primary_10_7759_cureus_42300 crossref_primary_10_1002_mco2_212 crossref_primary_10_1186_s13054_024_04994_0 crossref_primary_10_1093_nutrit_nuae074 crossref_primary_10_2147_VHRM_S379874 crossref_primary_10_7759_cureus_61045 crossref_primary_10_1016_j_hnm_2025_200316 crossref_primary_10_1016_j_numecd_2025_104365 crossref_primary_10_1080_19490976_2024_2390164 crossref_primary_10_1016_j_jand_2024_05_015 crossref_primary_10_2147_DMSO_S448165 crossref_primary_10_3390_nu16132028 crossref_primary_10_1186_s12974_022_02474_2 crossref_primary_10_3390_nu15204313 crossref_primary_10_5713_ab_21_0483 crossref_primary_10_1002_oby_23568 crossref_primary_10_1097_MCO_0000000000001135 crossref_primary_10_1097_MD_0000000000043800 crossref_primary_10_3389_fcvm_2022_925080 crossref_primary_10_1016_j_fbio_2025_107321 crossref_primary_10_1016_j_bonr_2025_101876 crossref_primary_10_1016_j_arr_2024_102274 crossref_primary_10_3389_fnut_2024_1325894 crossref_primary_10_1038_s41366_025_01823_4 crossref_primary_10_1097_HC9_0000000000000212 crossref_primary_10_1016_j_physbeh_2023_114431 crossref_primary_10_1017_cts_2023_646 crossref_primary_10_1002_advs_202204487 crossref_primary_10_3390_nu17061029 crossref_primary_10_1055_a_1677_2334 crossref_primary_10_3389_fnut_2024_1342787 crossref_primary_10_3748_wjg_v31_i22_108815 crossref_primary_10_11648_j_ijcems_20251101_12 crossref_primary_10_1038_s44324_024_00041_2 crossref_primary_10_3390_nu14235022 crossref_primary_10_1007_s13668_024_00532_0 crossref_primary_10_1055_a_2119_3516 crossref_primary_10_1038_s41366_023_01416_z crossref_primary_10_1016_j_numecd_2023_05_005 crossref_primary_10_3390_nu17020300 crossref_primary_10_23736_S0392_9590_24_05310_0 crossref_primary_10_3390_nu15061348 crossref_primary_10_1016_j_jnha_2025_100480 crossref_primary_10_1016_j_yexcr_2024_114261 crossref_primary_10_1096_fj_202500875R crossref_primary_10_3390_nu15234898 crossref_primary_10_1007_s10522_025_10301_3 crossref_primary_10_1016_j_dsx_2025_103279 crossref_primary_10_1093_nutrit_nuad104 crossref_primary_10_1159_000527838 crossref_primary_10_1016_j_cjca_2024_02_004 crossref_primary_10_1186_s41983_023_00623_9 crossref_primary_10_1186_s40795_023_00753_6 crossref_primary_10_1016_j_otc_2025_08_001 crossref_primary_10_3390_nu14112315 crossref_primary_10_3389_fnut_2022_979702 crossref_primary_10_1016_j_medcle_2023_06_008 crossref_primary_10_1055_a_1835_5612 crossref_primary_10_7759_cureus_28800 crossref_primary_10_3390_cancers16112079 crossref_primary_10_3389_fnut_2025_1524125 crossref_primary_10_1186_s12967_024_05738_y crossref_primary_10_1007_s44187_025_00422_6 crossref_primary_10_1016_j_clnesp_2025_06_051 crossref_primary_10_1186_s12909_024_06596_4 crossref_primary_10_1161_HYPERTENSIONAHA_125_24857 crossref_primary_10_1016_j_clinthera_2024_05_005 crossref_primary_10_1093_nutrit_nuae001 crossref_primary_10_1002_adbi_202200337 crossref_primary_10_1080_10408398_2022_2088687 crossref_primary_10_1016_j_arr_2024_102588 crossref_primary_10_3390_nu16244275 crossref_primary_10_1097_TIN_0000000000000372 crossref_primary_10_3390_nu15173724 crossref_primary_10_1016_j_medcli_2023_06_012 |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.1146/annurev-nutr-052020-041327 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Diet & Clinical Nutrition |
| EISSN | 1545-4312 |
| ExternalDocumentID | 34633860 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: R01 DK119783 |
| GroupedDBID | --- -QD -QH 04C 0R~ 1KX 36B 39C 4.4 51A 5FA 5FB 5FC 5FD 5FE 5FF 5GY 5RE 6PF 7A. 85S AABJL AAFWJ AAGWO AALHT AALUV AAOHI AAQMF AARJV AAWJP AAWTL AAXSQ AAYIS ABDOG ABGRM ABIPL ABJNI ABKGM ABOCM ABVYV ABZNY ACAHA ACDVT ACGFS ACGOD ACJYF ACKHT ACMXS ACPHO ACQCJ ACQLW ACRLM ACSOE ADANS ADHEY ADLON ADNJN ADOJX ADSVE AEAIQ AEKBM AENEX AEPIK AFCZG AFERR AFKDQ AFKEJ AFONB AFRAH AGBCJ AHIXL AHKZM AHMBA AHVNO AICBU AIDEK AIJFW AIZOL AJAAW ALAFQ ALIPV ALMA_UNASSIGNED_HOLDINGS AMTJG AOUBY AQQLW ATAUN B9D B9E B9F B9G B9H B9L B9N BCFVH BJPMW BMYRD CS3 E.L EBS EMB EST F-Q F-S F-V F-X F-Y F-Z F5P FIWKU FIXEU FMZAJ FQMFW FT0 FU. FUEKT FXG GJQJI GLOEX GNDDA GOAVI GQXMV H13 HZ~ J1V L7B M22 N9A NEJ NPM O9- P2P RAR RAV UBH WH7 YSK ZYWBE ~KM 7X8 RIG TUS |
| ID | FETCH-LOGICAL-a375t-80869caaba046fdfafb1ff6b009e65ff00532b96d3af11e0ffee750de8fbc7962 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 115 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708922400014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1545-4312 |
| IngestDate | Thu Oct 02 08:45:38 EDT 2025 Mon Jul 21 06:08:12 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | sleep time-restricted eating gut microbiome intermittent fasting safety appetite 5:2 diet cardiometabolic health alternate-day fasting |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a375t-80869caaba046fdfafb1ff6b009e65ff00532b96d3af11e0ffee750de8fbc7962 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 34633860 |
| PQID | 2581281217 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2581281217 pubmed_primary_34633860 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-11 |
| PublicationDateYYYYMMDD | 2021-10-11 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annual review of nutrition |
| PublicationTitleAlternate | Annu Rev Nutr |
| PublicationYear | 2021 |
| SSID | ssj0009333 |
| Score | 2.6319466 |
| SecondaryResourceType | review_article |
| Snippet | This review aims to summarize the effects of intermittent fasting on markers of cardiometabolic health in humans. All forms of fasting reviewed... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 333 |
| Title | Cardiometabolic Benefits of Intermittent Fasting |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34633860 https://www.proquest.com/docview/2581281217 |
| Volume | 41 |
| WOSCitedRecordID | wos000708922400014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UevDio_VRX6wg3habTZrHSWq1eNDQg0pvZbO7A4E2qc1W8N87u02pF0HwkkNgQ1jm8X0zHzOEXHOllAeBZBgeOQskBOhzYJU7UknLIHyn8n1_jtI0Ho2SYV1wq2pZ5SomukCtSmlr5Le8G9umDyLou9kHs1ujbHe1XqGxSRo-Qhlr59FoPS0cyboT2CNKYJgoeT109MeSF1YszJxZLQi3KkekZtHvUNOlnMHef392n-zWYJP2ltZxQDZ00SStXoFEe_pFb6iTf7q6epO0H3Jt8F09KHRC09Wc_hbp9J1qdaoNmswkl_QeIyTkpqIlUFdTnOYGwbehA1FZHfUheRs8vvafWL1qgQk_6hrMU3GYSCEygXwZFAjIPIAQfTLRYRfA-irPklD5AjxPdwC0RqyhdAyZjJKQH5Gtoiz0CaHcl0GUIW-U-C3AU57tZIrMrrTXPONtcrW6szGasu1PiEKXi2q8vrU2OV5e_Hi2nLkx9oMQyXTYOf3D6TOyw63yxOpOvHPSAHRkfUG25afJq_mlsxF8psOXb_Nbxg4 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiometabolic+Benefits+of+Intermittent+Fasting&rft.jtitle=Annual+review+of+nutrition&rft.au=Varady%2C+Krista+A&rft.au=Cienfuegos%2C+Sofia&rft.au=Ezpeleta%2C+Mark&rft.au=Gabel%2C+Kelsey&rft.date=2021-10-11&rft.issn=1545-4312&rft.eissn=1545-4312&rft.volume=41&rft.spage=333&rft_id=info:doi/10.1146%2Fannurev-nutr-052020-041327&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1545-4312&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1545-4312&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1545-4312&client=summon |